Chain Drug Review - Norvasc patent
March 19, 2007 -- Pfizer Inc, has won a federal court ruling involving its patent for Norvasc, a blood-pressure drug. Mylan Laboratories Inc., which hopes to make a...
AFP - Philippines seeks end of Pfizer Norvasc patent
May 8, 2007 -- MANILA (AFP) — A state-owned Philippine company on Tuesday urged regulators to cancel the patent held by pharmaceutical giant Pfizer on a...
M2 Presswire - Sanofi Pasteur Begins Shipments of Influenza Vaccine and Pfizer's Norvasc Patent Upheld.
September 4, 2006 -- M2 PRESSWIRE-4 September 2006-U.S. Equity News: Sanofi Pasteur Begins Shipments of Influenza Vaccine and Pfizer's Norvasc Patent Upheld(C)1994-2006...
Chain Drug Review - Pfizer to appeal Norvasc ruling
January 20, 2003 -- Pfizer Inc. plans to appeal a federal court decision to dismiss its patent infringement suit against Dr. Reddy's Laboratories Ltd. over the drug...
Pharmaceutical Processing - Norvasc ALLHAT review cancelled.(Noted)
April 1, 2005 -- Norvasc ALLHAT review cancelled: FDA's Cardiovascular & Renal Drugs April 5 review of supplemental indications for Pfizer's Norvasc based on...
Medical Marketing and Media - 'Shortcut' generic of Norvasc approved
December 1, 2003 -- USING A LEGAL shortcut, India's Dr. Reddy's Laboratories received FDA approval for a near-generic version of Norvasc (amlodipine), the world's...
Chain Drug Review - Dr. Reddy's offers generic version of Norvasc
November 24, 2003 -- BOMBAY -- Dr. Reddy's Laboratories Ltd. has received final Food and Drug Administration approval to market a generic version of Norvasc, Pfizer...
Chain Drug Review - Dr Reddy's sued over Norvasc
July 22, 2002 -- Dr Reddy's Laboratories has been sued by Pfizer Inc. for allegedly infringing on the latter's patent for Norvasc, an antihypertension drug. Dr...
Pharma Marketletter - Novartis' Diovan as effective as Norvasc in hypertensive patients with high CVD risk.
June 28, 2004 -- Results have been published in The Lancet from the eagerly-awaited VALUE (Valsartan Antihypertensive Long-term Use Evaluation) trial, which compared...
M2 Presswire - Pfizer wins Norvasc patent challenge by generic manufacturer Apotex and U.S. BioDefense, Inc. files grant to test diagnostics for chemical and biological agent...
January 19, 2006 -- M2 PRESSWIRE-19 January 2006-US Financial Network: Pfizer wins Norvasc patent challenge by generic manufacturer Apotex and U.S. BioDefense, Inc....
